Salpingo Oophorectomy

To reduce the risk of ovarian or breast cancer some choose to have a procedure done known as an oophorectomy. This is a removal of your ovaries on each side of your uterus that contain eggs and secrete the hormones that control your reproductive cycle. This greatly reduces the amount of hormones estrogen and progesterone circulating in your body which is the hormones breast and ovarian cancers need to grow. Though a generally safe procedure with small risk complications

Some primary prevention measures such as prophylactic oophorectomy in young women(35 and under) has shown to reduce the breast cancer by 60 percent but this surgery comes with many unpleasant symptoms. Such as mood changes, night sweats and hot flashes etc.

According to sources, the US Preventive Services Task Force advises against pelvic exam procedure--calculating to 63 million (REFERENCE) performed half a decade ago--for healthy women because specific illnesses (i.e., ovarian cancer) have not decreased; however, doctors argue with the American College of Obstetricians and Gynecologists retreat to advocate further usage of the pelvic exam treatment due to the lack of evidence showing the benefits towards 'asymptomatic women" (Amir Qaseem, VP of AMERICAN COLLEGE OF PHYSICIANS).

Due to the significance, of the hormones and organs involved in the Hypothalamic-Pituitary-Ovarian axis, removal of ones of these organs could have detrimental side-effects for the patient, however, the ovary is often removed for numerous reasons. Therefore, knowing the effects of removing the ovary could have significant clinical implications in patient management and care. Thus the information produced by this study could potentially improve the lives of ovarian cancer patients and provide valuable data to clinicians and researchers. However, the results or conclusions produced by this data could also benefit women that experience menopause as the ovaries are no longer receptive to gonadotrophic signals, producing no estrogen as a result

2. Herzog, T. J., Armstrong, D. K., Brady, M. F., Coleman, R. L., Einstein, M. H., Monk, B. J., . . . Alvarez, R. D. (2014). Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper. Gynecologic Oncology,132(1), 8-17. doi: 10.1016/j.ygyno.2013.11.008

As many as 1,400 women in Canada are diagnosed with cancer of the cervix each year. More than 400 die from it (Mah et al, 2011).

Breast cancer and ovarian cancer are both very serious and devastating diseases. The National Cancer Institute estimates that more than 250 thousand people will be diagnosed with breast cancer this year, and over 40 thousand will die from the disease.

It is an operation to remove the uterus. Most hysterectomies are performed to treat conditions such as fibroids, heavy bleeding, endometriosis, adenomyosis, uterine prolapse, and cancer. This may cause depression to some individuals (Vomvolaki et al., 2006).

A hysterectomy is a medical procedure to remove part or all of the womb. It is an operation to treat a number of female uterine problems that did not respond to other medical treatments. The main non-cancerous issues treated with a hysterectomy are uterine fibroids, heavy menstrual bleeding, constant pelvic pain, cervical dysplasia, and uterine prolapse. After a physical examination and diagnosis of your individual symptoms and overall medical history, your Glendora General Surgeon will discuss your surgical options and make a recommendation for the best procedure for you.

Obesity is another cause for women to develop ovarian cancer because they have too much body mass, compared to women who have a normal weight. In addition, women

In a total hysterectomy with salpingo-oophorectomy,the uterus plus one ovary and Fallopian tubes are removed surgically.

Breast cancer has been acknowledged for centuries, with records dating as far back as the ancient Egyptians, over 3500 years ago (1). However diagnosis, research and progress throughout history have been slow due to it being a matter of taboo and humiliation. In 1957 the idea of surgically removing the tumours was suggested by Henri Le Dran, introducing mastectomy to the 20th century; the first scientific step in acting against cancer. Radical mastectomy lengthened survival, however was often declined due to the disfigurement left behind. To overcome this, Bernard Fisher published results from ‘breast conserving’ surgery accompanied by radiation or chemotherapy, which were ‘just as effective’ as a radical mastectomy (1).

The study protocol was approved by the institutional ethics committee and informed consent was obtained from the patients. Women with infertility, abnormal uterine bleeding, abnormal finding on ultrasound examination or hysterosalpingography and missed intrauterine device were recruited to the study. Contraindications for the office hysteroscopy were severe bleeding, history of severe cardiovascular disease, endometrial neoplasia and suspicion of pregnancy. Moreover, patients with a history or suspicion of pelvic inflammatory disease were excluded from the

Ms. Brown is a 37-year old female who visited the High Risk Break and Ovarian Cancer Clinic due to a previous history of a mass palpation on her breast during a routine breast exam in 2006. Ms. Brown has the mass inspected by a clinician as well as a mammogram. The mammogram showed that “showed a suspicious finding” (Stanhope, 2012). A breast biopsy was performed and results showed atypical ductal hyperplasia, followed by a lumpectomy. The results of the lumpectomy were benign. Her past medical history includes endometriosis, which lead to a total abdominal hysterectomy and bilateral salpingo-oophorectomy in 1996. She briefly took hormone replacement therapy prior to the finding of her breast mass. Her family history is no stranger

Ovarian cancer is the most deadly gynecological cancer and remains a formidable challenge because 70% of the women are diagnosed only in advanced stage[1]. Every year 2.5 lakh new cases of ovarian malignancy are detected. Ovarian cancer is the third most common cancer in Indian women. Primary cyto-reductive surgery and chemotherapy remains the standard treatment for ovarian malignancy. The best opportunity to treat ovarian cancer occurs at the time of initial laparotomy. Ideally patients with ovarian malignancy should be operated by a gynecologic